I graduated with Masters in Pharmaceutical Sciences from Campbell University, NC. My industry experience of 5 years involves quality and manufacturing specialties for inhalation dosages and formulation & drug development for ocular delivery products coupled with medical devices. I am currently working as a process scientist for Lipid Nanoparticles (LNP) process development group at Intellia Therapeutics, Cambridge, MA. In this role, I work on developing next generation processes for LNPs as a delivery medium for gene-editing RNA modalities where I am engaged in developing process improvement scope, process characterization and identifying and implementing new technology trends in the LNP process.
With continuous learning and exploring across various areas of biotech industry, I am excited to be a part of the programming committee for the Interphex 2024 conference which is a great platform for knowledge exchange for industry leaders and professionals.